Diaphragmatic Function as a Biomarker
NCT05903001 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2026-01-28
Summary
Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Diaphragm Ultrasound
Ultrasound of the Diaphragm at the end of inspiration and expiration
- DIAGNOSTIC_TEST
-
Intercostal Muscle Ultrasound
Ultrasound of the Intercostal Muscles at the end of inspiration and expiration
- DIAGNOSTIC_TEST
-
Borg scale
Questionnaire for Perceived Exertion (Borg Rating of Perceived Exertion Scale)
- DIAGNOSTIC_TEST
-
MRC Breathlessness Scale
The MRC Dyspnoea Scale allows the patients to indicate the extent to which their breathlessness affects their mobility.
- DIAGNOSTIC_TEST
-
Respiratory Questionaire
Specialized respiratory questionnaire with different domains (Emotional Domain, Dyspnea Domain, Mastery Domain, Fatigue Domain)
- DIAGNOSTIC_TEST
-
GINA classification of Asthma
Patients are classified according to the GINA classification of Asthma.
- DIAGNOSTIC_TEST
-
Measurement of respiratory mouth pressure
Inspiratory and expiratory Measurement of respiratory mouth pressure
- DIAGNOSTIC_TEST
-
SNIP
Measurement of Sniff Nasal Inspiratory Pressure
- DIAGNOSTIC_TEST
-
6-minute walking distance
The maximum walking distance achieved in 6 minutes
- DIAGNOSTIC_TEST
-
60 seconds sit-to-stand test
number of repetitions achieved in sitting down and standing up in 60 seconds
- DIAGNOSTIC_TEST
-
Electromyography
electromyography of the muscles of respiration via superficial electrodes
- DIAGNOSTIC_TEST
-
Lung Function
Measurement of lung function via body plethysmography
- DIAGNOSTIC_TEST
-
CAT-Questionnaire
COPD Assessment Test (CAT)
- DIAGNOSTIC_TEST
-
European Society of Cardiology (ESC)/ European Respiratory Society (ERS) risk group
Patients with pulmonary hypertension are classified according to the ESC/ERS risk group.
Sponsors & Collaborators
-
RWTH Aachen University
lead OTHER
Principal Investigators
-
Michael Dreher, MD · Uniklinik RWTH Aachen
-
Binaya Regmi, MD · Uniklinik RWTH Aachen
-
Jens Spiesshoefer, MD · Uniklinik RWTH Aachen
-
Mustafa Elfeturi · Uniklinik RWTH Aachen
-
Benedikt Jörn · Uniklinik RWTH Aachen
-
Faniry Ratsimba · Uniklinik RWTH Aachen
-
Felix Wagner · Uniklinik RWTH Aachen
-
Maria Aetou, Dr. med. · RWTH Aachen University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2026-12-30
- Completion
- 2026-12-30
Countries
- Germany
Study Locations
More Related Trials
-
Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea
NCT01197586 ·Status: COMPLETED
-
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
NCT01274507 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
NCT02245178 ·Status: COMPLETED
-
Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence
NCT03029936 ·Status: COMPLETED
-
Biomarkers in Dyspnea
NCT03056547 ·Status: COMPLETED ·Phase: NA
-
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
NCT05145894 ·Status: UNKNOWN
-
Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)
NCT04332198 ·Status: UNKNOWN ·Phase: NA
-
The Difference in the Biological Characteristic Characteristics of the Heart and Lung Meridians
NCT05690217 ·Status: COMPLETED
-
Detect and Infer the Severity of COPD by Intelligent Terminal Device
NCT05551169 ·Status: COMPLETED
-
The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
NCT06918353 ·Status: NOT_YET_RECRUITING
-
Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)
NCT05724745 ·Status: RECRUITING ·Phase: NA
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
NCT01631162 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
NCT02827734 ·Status: UNKNOWN
-
Evaluation of the Multidimensional Dyspnea Profile (MDP)
NCT04090671 ·Status: UNKNOWN ·Phase: NA
-
Biomarker in Lung Diseases
NCT00989846 ·Status: UNKNOWN
-
Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases
NCT02229994 ·Status: COMPLETED
-
Measuring Lung Mechanics in Patients with COPD Using the REOM Handheld Portable Device
NCT05913323 ·Status: COMPLETED
-
Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease
NCT06539962 ·Status: COMPLETED
-
Assessment of Oral and Nasal Breathing With Sensors Analyzing Algorithm
NCT05869071 ·Status: RECRUITING
-
Sonographic Diaphragm Function in AECOPD
NCT05671198 ·Status: RECRUITING
-
Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
NCT00756522 ·Status: COMPLETED
-
Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease
NCT02826265 ·Status: UNKNOWN
-
Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935 ·Status: ACTIVE_NOT_RECRUITING
-
Deep Learning Diagnostic and Risk-stratification for IPF and COPD
NCT05318599 ·Status: RECRUITING